Skip to content
RDL Network logo
1068P Phase II trial of fecal microbiota transplantation (FMT) plus immune checkpoint inhibition (ICI) in advanced non-small cell lung cancer and cutaneous melanoma (FMT-LUMINate) — Arielle Elkrief (2024) | RDL Network